Burkhardt Glen

VP, Human ResourcesPhaseBio Pharmaceuticals Inc (PHAS) · full profile →Form 4 · filed Nov 23, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 19, 2021Sell(S)6K$2.37$14K0
Nov 19, 2021Grant(A)6K$2.01$12K6K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001169245-21-000125) within minutes of acceptance. Every field above traces to the original document. Verify it directly: